Valery A. Shelyakin

Valery A. Shelyakin

Auto-generated profile, based on publicly available information

Valery A. Shelyakin

Territorial fund of compulsory medical insurance of the Sverdlovsk region

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2022 in National Health Care (Russia)
Verified
Journal Article
Open access
PDF file
TZT. A. Zherebtsova
T. A. Zherebtsova
SLS. L. Leontiev
S. L. Leontiev
DMD. O. Mikhailova
D. O. Mikhailova
VSV. A. Shelyakin
V. A. Shelyakin
Nowadays, creation of a new medical organization model providing primary healthcare services (New Model) is broadly associated with the introduction of lean manufacturing technologies. In the setting of modern healthcare development, the challenge of evaluating the efficiency of the medical organization activities remains primary and unresolved, especially in the context of introduction of new methodological approaches. The article describes the experience of creating and evaluating the efficiency of the New Model implementation in medical organizations of the Sverdlovsk region operating in the compulsory medical insurance system.The purpose of the study. To present the results of evaluating the effectiveness of the implementation of the New Model in medical organizations in the Sverdlovsk region.Research materials. The activities of 79 medical organizations involved in the New Model creation and expansion in the period between 2017 and 2019 were analyzed.Research results. The rate of staff involvement in the medical organizations was examined using an express “Questionnaire Q12” method; herewith 1,489 employees were interviewed in 2018, and 3,640 employees in 2019. The level of patient satisfaction with the medical care quality and availability, the number and amounts of fines/deductions/withdrawals for the outpatient care services collected by insurance medical organizations (IMOs), Territorial Fund of Compulsory Medical Insurance of the Sverdlovsk Region (TFCMI SR) were studied.Conclusion. The New Model implementation increases the level of patient satisfaction with the medical care quality and availability, the number of fines/deductions for the outpatient care services collected by IMOs, TFCMI SR has been decreased. A high staff involvement in the medical organization activities has been observed, however certain activities aimed at satisfying the HR needs and staff motivation need to be developed. It is necessary to continue further evaluation of the efficiency of the New Model implementation in terms of medical, social and economic indicators. Crucial in the New Model implementation is the interaction between TFCMI SR, IMOs, and medical organizations in the provision of primary healthcare services aimed at the assessment of the medical care availability and quality, including patient satisfaction.

15 March 2021 in Russian Journal of Allergy
Verified
Journal Article
Open access
EBEvgeny K. Beltyukov
Evgeny K. Beltyukov
VSValery A. Shelyakin
Valery A. Shelyakin
VNVeronika Naumova
Veronika Naumova
AVAlexander V. Vinogradov
Alexander V. Vinogradov
OSOlga G. Smolenskaya
Olga G. Smolenskaya
BACKGROUND: Biologicals use in severe asthma (SA) is associated with targeted therapy (TT) availability problem. Ensuring the availability of biologicals can be resolved within the territorial compulsory medical insurance program (TCMIP) in day-stay or round-the-clock hospital. AIMS: This study aimed to develop and implement a program for immunobiological therapy (IBT) introduction for SA in Sverdlovsk Region (SR). MATERIALS AND METHODS: Program for introduction of IBT for SA was developed in SR in 2018 to provide patients with expensive biologicals within the TCMIP. Program includes the following: SA prevalence study in SR; practitioners training in differential diagnosis of SA; organization of affordable therapy for patients with SA; registration of patients with SA сreation and maintenance; and selection and management of patients with SA in accordance with federal clinical guidelines. RESULTS: Atopic phenotype in SA was detected in 5%, eosinophilic ― in 2.3% of all analyzed cases of asthma (n=216). Practitioners of SR were trained in differential diagnosis of SA. Orders of the Ministry of Health of SR were issued as follows: regulating the procedure for referring patients with SA to IBT, with a list of municipal medical organizations providing IBT in a day-stay or round-the-clock hospital; approving regional registration form of patients with SA requiring biologicals use; ungrouping of clinical and statistical groups of day-stay hospital was depending on INN and dosage of biologicals; and selecting patients with SA for TT and including them in the regional register. Initiating of TT in round-the-clock hospital and continuation therapy in day-stay hospital provides a significant savings in compulsory medical insurance funds. CONCLUSIONS: IBT introduction for SA in SR is carried out within the framework of the developed program. Principle of decentralization brings highly specialized types of medical care closer to patients making it possible to provide routine medical care in allergology-immunology profile in the context of restrictions caused by coronavirus disease 2019 pandemic.